Study Shows Tralokinumab Does Not Significantly Reduce Asthma Exacerbations in … – Lung Disease News


Lung Disease News

Study Shows Tralokinumab Does Not Significantly Reduce Asthma Exacerbations in
Lung Disease News
Results from a recent study published in The Lancet Respiratory Medicine showed that Tralokinumab did not significantly reduce the rates of asthma exacerbation in patients with severe uncontrolled asthma. However, the results revealed that tralokinumab …

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.